Literature DB >> 34604873

In vitro and in silico evaluation of EGFR targeting activities of curcumin and its derivatives.

Yuan Liang1, Jingqi Zhao1, Haoyang Zou1, Jie Zhang1, Tiehua Zhang1.   

Abstract

As polyphenols from Curcuma longa, curcumin and its derivatives possess numerous bioactivities. Herein, the epidermal growth factor receptor (EGFR) targeting activities of curcumin and its derivatives, as well as their structure-activity relationship were investigated. All of the tested compounds exhibited significant inhibition activities against EGFR kinase in homogeneous time-resolved fluorescence assay. Then their antiproliferative activities against Caco-2 were confirmed. The expressions of EGFR and phospho-EGFR proteins were regulated by curcumin and its derivatives. The 3,5-dione and methoxyl groups exerted significant influence on their electrostatic interactions with EGFR. Both hydrogen bonds and hydrophobic contacts were crucial for their binding with EGFR. Interestingly, their EGFR targeting activities were structure-dependent. The binding stabilities of curcumin and its derivatives were different from each other due to their structural diversity. This work indicated that curcumin and its derivatives were potential tyrosine kinase inhibitors that target EGFR.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34604873     DOI: 10.1039/d1fo02002a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  4 in total

Review 1.  Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules.

Authors:  Matteo Costantino; Cristina Corno; Diego Colombo; Paola Perego
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

2.  Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis.

Authors:  Fei-Ran Yang; Si-Yi Li; Xi-Wen Hu; Xiu-Rong Li; Hui-Jie Li
Journal:  Drug Des Devel Ther       Date:  2022-07-23       Impact factor: 4.319

3.  Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study.

Authors:  Adam Hermawan; Febri Wulandari; Naufa Hanif; Rohmad Yudi Utomo; Riris Istighfari Jenie; Muthi Ikawati; Ahmad Syauqy Tafrihani
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

4.  Identification of 20(S)-Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor.

Authors:  Yuan Liang; Jingqi Zhao; Haoyang Zou; Jie Zhang; Tiehua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-24       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.